Patient Preferences in Drug Development and Evaluation

10k
Total downloads
47k
Total views and downloads

Articles

SYSTEMATIC REVIEW

Published on 26 Oct 2020

Use of Patient Preference Information in Benefit–Risk Assessment, Health Technology Assessment, and Pricing and Reimbursement Decisions: A Systematic Literature Review of Attempts and Initiatives

Lylia Chachoua
Monique Dabbous
Clément François
Claude Dussart
Samuel Aballéa
Mondher Toumi

doi 10.3389/fmed.2020.543046

5,846 views
25 citations

ORIGINAL RESEARCH

Published on 17 Jul 2020

Social Preferences for Orphan Drugs: A Discrete Choice Experiment Among the French General Population

Mondher Toumi
Aurélie Millier
Olivier Cristeau
Katia Thokagevistk-Desroziers
Julie Dorey
Samuel Aballéa

doi 10.3389/fmed.2020.00323

2,384 views
13 citations

ORIGINAL RESEARCH

Published on 03 Jul 2020

“Co-production Compass” (COCO): An Analytical Framework for Monitoring Patient Preferences in Co-production of Healthcare Services in Mental Health Settings

Guendalina Graffigna
Serena Barello
Lorenzo Palamenghi
Fabio Lucchi

doi 10.3389/fmed.2020.00279

4,227 views
7 citations

ORIGINAL RESEARCH

Published on 20 Mar 2020

Patient Centricity in Patient Preference Studies: The Patient Perspective

Eline van Overbeeke
Inès Vanbinst
Aura Cecilia Jimenez-Moreno
Isabelle Huys

doi 10.3389/fmed.2020.00093

7,075 views
19 citations

HYPOTHESIS AND THEORY

Published on 24 Apr 2019

Patient Preference Studies During Early Drug Development: Aligning Stakeholders to Ensure Development Plans Meet Patient Needs

Nigel S. Cook
Julie Cave
Anke-Peggy Holtorf

doi 10.3389/fmed.2019.00082

11,506 views
45 citations

ORIGINAL RESEARCH

Published on 03 Apr 2019

The Patient Perspectives on Future Therapeutic Options in NASH and Patient Needs

Nigel Cook
Andreas Geier
Andreas Schmid
Gideon Hirschfield
Achim Kautz
Jörn M. Schattenberg
Maria-Magdalena Balp

doi 10.3389/fmed.2019.00061

6,819 views
30 citations

ORIGINAL RESEARCH

Published on 11 Oct 2018

Patient Involvement in the Lifecycle of Medicines According to Belgian Stakeholders: The Gap Between Theory and Practice

Rosanne Janssens
Eline van Overbeeke
Lotte Verswijvel
Lissa Meeusen
Carolien Coenegrachts
Kim Pauwels
Marc Dooms
Hilde Stevens
Steven Simoens
Isabelle Huys

doi 10.3389/fmed.2018.00285

6,380 views
14 citations

Share on

Frontiers in Medicine

Regulatory Science

Impact

47kTopic views
35kArticle views
10kArticle downloads

View impact

Articles

Use of Patient Preference Information in Benefit–Risk Assessment, Health Technology Assessment, and Pricing and Reimbursement Decisions: A Systematic Literature Review of Attempts and Initiatives

Social Preferences for Orphan Drugs: A Discrete Choice Experiment Among the French General Population

“Co-production Compass” (COCO): An Analytical Framework for Monitoring Patient Preferences in Co-production of Healthcare Services in Mental Health Settings

Patient Centricity in Patient Preference Studies: The Patient Perspective

Patient Preference Studies During Early Drug Development: Aligning Stakeholders to Ensure Development Plans Meet Patient Needs

The Patient Perspectives on Future Therapeutic Options in NASH and Patient Needs

Patient Involvement in the Lifecycle of Medicines According to Belgian Stakeholders: The Gap Between Theory and Practice

Frontiers in Medicine

Regulatory Science